CagriSema
5 mg / 5 mg
Co-formulated semaglutide and cagrilintide, 5 mg of each per vial.
- Storage
- Refrigerated
Comparison
Two different answers to the same research question: what happens when you recruit more than one pathway at once. One combines two molecules acting on separate systems; the other is a single molecule engineered to hit three receptors.
CagriSema answers whether two independent satiety mechanisms are additive, and because it is two molecules you can run each alone to find out. Retatrutide asks a different question: what a single molecule does when it also recruits energy expenditure through glucagon. The pairing is a combination study; the triple agonist is a mechanism study. Neither is a stronger version of the other.
| Property | CagriSema | Retatrutide |
|---|---|---|
| Composition | Two peptides co-formulated in one vial | One engineered peptide |
| Pathways engaged | GLP-1 plus amylin | GIP, GLP-1 and glucagon |
| Mechanism class | Incretin plus a non-incretin satiety pathway | Triple incretin and glucagon agonism |
| Energy expenditure arm | Absent. Both components act on satiety and glucose | Present, through the glucagon receptor |
| Separability in study | The two components can be studied apart, which isolates each contribution | Single molecule; the three activities cannot be separated |
| Regulatory status | Neither component approved in this combination | Not approved in any market |
| Price | $116.00 · 5 mg / 5 mg | $89.00 · 10 mg |
5 mg / 5 mg
Co-formulated semaglutide and cagrilintide, 5 mg of each per vial.
10 mg
Triple GIP, GLP-1 and glucagon receptor agonist, 10 mg per vial.
Two. It is semaglutide and cagrilintide co-formulated in a single vial. Retatrutide by contrast is one engineered molecule carrying three receptor activities.
Retatrutide. CagriSema works through GLP-1 and amylin, both of which act on satiety and glucose signalling. Neither of its components engages glucagon.
Yes. Semaglutide and cagrilintide are both stocked individually, which is what makes it possible to study each contribution on its own before combining them.
All products listed are sold strictly for in-vitro laboratory research and analytical use. They are not drugs, foods, cosmetics or medical devices, and are not intended to diagnose, treat, cure or prevent any disease.
PPS assistant
Catalogue, handling, shipping and payment
Research use only. No dosing or medical advice. A person: Info@purepeptidesources.com